Self-reported and tracker-estimated physical activity outcomes in women with chronic pelvic pain disorders: A longitudinal evaluation of construct validity
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
This study aims to evaluate the short form International Physical Activity Questionnaire (IPAQ) for use in women with chronic pelvic pain disorders (CPPDs) by comparing its scores against objectively-estimated physical activity (PA) outcomes. We investigated IPAQ components that are most consistently predictive of habitual PA behavior.
Method
The study sample included 966 weeks of data from 112 women with CPPDs who enrolled in a 14-week mHealth-based self-tracking study. Participants wore Fitbit devices and completed the IPAQ every week. We compared the IPAQ-reported minutes of walking, total activity, sitting, light-, moderate-, and vigorous intensity PA for concordance and divergence against their corresponding Fitbit estimates. We used linear mixed-effects regression models (MLMs) for all analyses and quantified the between-participant variance in the magnitude of agreement between the two methods via random slope terms. We further evaluated temporal consistency in scores using intraclass correlation coefficients (ICCs).
Results
IPAQ-reported walking minutes were strongly associated with Fitbit step counts (B = 3952.36; p = 0.006), minutes of moderate PA (B = 15.498; p = 0.0113), and moderate-to-vigorous PA (MVPA; B = 28.973; p = 0.007). IPAQ total activity minutes were associated with Fitbit minutes of vigorous PA (B = 15.183; p = 0.007) and MVPA (B = 25.658; p = 0.010). IPAQ moderate activity minutes were predictive of Fitbit vigorous PA minutes (B = 9.060; SE = 3.719; p = 0.0151). There was substantial between-individual variance in these point estimates based on the significant random-effect terms, and average weekly PA level was a significant moderator of the association between IPAQ-reported and Fitbit-estimated scores for these variables. IPAQ-reported sitting minutes were inversely associated with Fitbit step counts (B = - 3125.61; p = 0.004), and minutes of MVPA (B = -21.848; p = 0.007), vigorous AP (B = -10.854; p = 0.042), and moderate PA (B = -10.985; p = 0.004).
Conclusion
These findings provide support for using IPAQ-reported walking and total activity minutes to monitor several PA domains in women with CPPDs, given their concordance with several tracker-estimated PA outcomes. However, the item on “sitting time” may not be a suitable for assessing sedentary time.
